Archives

by in
Entry Author Date Location
Alkermes CEO Richard Pops on Building Big, Playing Well with Pharma 04/18/14 Boston
Alkermes Scores Phase 3 Win for Long-Lasting Schizophrenia Drug 04/08/14 Boston
East Coast Biotech Roundup: Proteon, Ataxion, NY Genome/Watson, & More 03/21/14 Boston
East Coast Biotech Roundup: VentriNova, RainDance, Biogen, & More 03/07/14 Boston
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More 02/28/14 Boston
The Big Guys Have Lost Their Iron Grip, and It’s All Good 01/20/14 National
East Coast Biotech Roundup: JP Morgan Edition 01/17/14 Boston
Alkermes Nabs $250M It Doesn’t Need, But Could Fend Off Barbarians 01/13/14 Boston
Xconomy Boston’s Top 10 Stories of Q4: Editor’s Picks 12/30/13 Boston
3 Life Sciences Companies That Are Built to Last 12/02/13 National
Gates Foundation Health Chief on Coaxing Pharma to Do Good 11/25/13 National
East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More 11/15/13 Boston
How Alkermes Survived a Brush With Death 11/11/13 National
East Coast Life Sciences Roundup: Verdine, Ariad, Karyopharm, & More 10/11/13 Boston
East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More 09/13/13 Boston
Civitas Scores $38M Series B For Parkinson’s Drug Push 09/11/13 Boston
East Coast Life Sciences Roundup: Alkermes, Ensemble, Sinai, & More 07/19/13 Boston
Alkermes Adds Cancer, MS Drugs To Growing Portfolio 07/17/13 Boston
East Coast Life Sciences Roundup: IPO Madness, Amicus, & More 06/21/13 Boston
Alkermes Spinout, Civitas, Nabs Second Grant From Fox Foundation 06/18/13 Boston
FDA Delay on New Drug Triggers Layoffs at San Diego’s Zogenix 06/05/13 San Diego
With $1.3M in Seed Funding, Arcturus Adds to RNAi Hub in San Diego 06/03/13 San Diego
East Coast Life Sciences Roundup: Epizyme, Alkermes, Ophthotech, & More 05/31/13 Boston
Alkermes Unveils Full Mid-Stage Data On Depression Drug 05/31/13 Boston
East Coast Life Sciences Roundup: Thermo, Alkermes, Acorda, Epizyme 04/19/13 Boston
Alkermes Stock Climbs on Positive Trial for Depression Drug 04/17/13 Boston
Some Bold Baseball and Biotech Picks for the 2013 Season 03/11/13 National
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
Biotech CEOs See Insurers as the New Boogeymen, Not FDA 01/07/13 National
East Coast Life Sciences Roundup: Pfizer, J&J, Alkermes, More 01/04/13 Boston
Page 1 of 6 next page »